Showing 3521 - 3530 of 4841 for "Investment funds" with applied filters
22 December 2021 by Ritch Mueller y Nicolau
We are pleased to announce the following lawyers as new partners of our firm
16 December 2021 by MLL Meyerlustenberger Lachenal Froriep
MLL is delighted to announce that Renato Bucher, Florian Müller and Christian Rebell will become partners of the firm on 1 January 2022.
15 December 2021 by Arendt & Medernach
Arendt is pleased to welcome Christian Heinen, who joined the group as the new CEO of Arendt Services on the first of December. He takes over for Olivier Hamou, who will remain on the company’s Board of Directors.
14 December 2021 by Arendt & Medernach
Arendt advised 468 SPAC I SE, a Luxembourg special purpose acquisition company (SPAC) sponsored by Alexander Kudlich, former Rocket Internet board member, Ludwig Ensthaler and Florian Leibert, in its successful business combination with Boxine GmbH ("Boxine")
13 December 2021 by Nestor Nestor Diculescu Kingston Petersen
NNDKP has assisted Safety Broker, the largest independent insurance broker operating in Romania and in the Republic of Moldova, in the sale of 80% of the company’s shares to the Unilink group, leader on the relevant Polish market.
10 December 2021 by Bahas Gramatidis & Partners
We kindly invite you to join our noble cause; the purchase of approx. 100,000 olive trees to replace the ones lost by the recent devastating fires in the surrounding of Ancient Olympia, Greece.
10 December 2021 by Arendt & Medernach
Arendt assisted Alvotech with all Luxembourg law aspects of the agreement to enter into a business combination with Oaktree Acquisition Corp. II in order to create a leading publicly traded global biopharmaceutical company
30 November 2021 by Arendt & Medernach
Stéphanie Lhomme has joined Arendt Regulatory & Consulting in the role of Director in order to strengthen Arendt’s advisory services offering to clients in the areas of Forensic Investigations, Anti-bribery & Corruption, and Corporate Intelligence.
24 November 2021 by L&L Partners
L&L Partners Law Offices advised the Carlyle Group (“Carlyle”), on setting up an integrated generic pharmaceuticals platform, known as Viyash Life Sciences Private Limited in partnership with ex-Mylan senior executive, Dr. Hari Babu Bodepudi and ex- founder of Laurus Labs, Dr. Srihari Raju Kalidindi. L&L has also advised Carlyle on all its follow-on investments into Viyash over a period of time.
24 November 2021 by L&L Partners
L&L Partners Law Offices advised the Carlyle Group on the acquisition of 100% stake of Appcure Labs Private Limited and the acquisition of majority stake in Appco Pharma LLC through its generic pharma platform, Viyash Life Sciences Private Limited.